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Abstract  A  41-year-old  man  underwent  a  Heller  myotomy  due  to  achalasia.  An  unexpected
puncture  in  the  esophageal  wall  was  identiﬁed  during  the  procedure.  A  partially  covered  15  cm
stent (PSEMS)  (UltraFlex)  was  placed  at  the  mucosal  defect.  It  was  removed  26  days  later  and
the endoscopic  image  showed  esophageal  tissue  embedded  in  the  covered  portion  of  the  stent.
PSEMS covering  loss  is  a  rare  complication  that  can  have  serious  consequences.
© 2012  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
rights reserved.
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Pérdida  total  de  la  cubierta  del  stent  metálico  en  el  tratamiento  de  una  fuga  esofágica
Resumen  Se  presenta  el  caso  de  un  hombre  de  41  an˜os  de  edad  al  cual  se  le  realizó  una
miotomía  de  Heller  por  acalasia.  Durante  el  procedimiento  se  identiﬁcó  una  punción  inadvertida
de la  pared  del  esófago.  Se  decide  la  aplicación  de  un  stent  parcialmente  cubierto  (PSEMS)  de
15 cm  (UltraFlex)  sobre  el  defecto  de  la  mucosa.  El  stent  fue  removido  26  días  después  y  la
imagen endoscópica  mostró  la  presencia  de  crecimiento  de  tejido  esofágico  sobre  la  sección
cubierta del  stent.  La  pérdida  de  la  cubierta  de  las  PSEMS  es  una  complicación  infrecuente  que,
sin embargo,  puede  llevar  a  serias  complicaciones.
© 2012  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
os.Todos los  derechos  reservad∗ Corresponding author at: S/N. Mitras Centro, Monterrey, Nuevo
Leon, Mexico. Tel.: +52 818 333 3664.
E-mail address: joseagonz@yahoo.com
(J.A. Gonzalez-Gonzalez).
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overed  self-expandable  metallic  stents,  initially  developed
o  avoid  esophageal  malignant  tissue  in-  and/or  over-
rowth,  are  now  being  used  successfully  to  treat  other
isorders  such  as  anastomotic  leaks,  benign  strictures,
austic  injury  stenoses,  aorto-esophageal  ﬁstula,  and  spon-
aneous  perforations.1,2 The  development  of  covered  stents
. Published by Masson Doyma México S.A. All rights reserved.
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with  a  complications  rate  of  5.6--16%.2,9
In  a  PubMed  search,  we  found  a  few  reports  about  the
safety  and  complications  (damage  of  the  cover)  of  PSEMS  inFigure  1  The  image  shows  the  stent  application.
as  increased  the  posibility  to  make  them  removable  and
otentially  useful  in  benign  GI  disease.3--5 We  present  the
ase  of  a  patient  with  an  esophageal  leak  treated  with  a
artially  covered  self  expandable  metallic  stent  (PSEMS).
ase report
 41-year-old  man  underwent  elective  laparoscopic  Heller
yotomy  for  achalasia;  during  the  procedure  a  perforation
f  the  esophageal  wall  was  observed,  and  primary  closure  of
he  defect  was  attempted.  The  patient  started  with  PO  on
ay  three,  but  he  complained  of  chest  pain  and  fever.  Imme-
iately  CT  scan  with  oral  contrast  was  performed.  A  free
eakage  at  esophago-gastric  junction  was  observed.  A  15  cm
SEMS  (Ultraﬂex  esophageal  NG  covered  (120  mm)  stent,
oston  Scientiﬁc,  Natick,  MA)  was  placed  across  the  defect,
eading  to  the  distal  1.5  cm  non  cover  into  the  stomach  and
he  proximal  1.5  cm  non  cover  at  30  cm  from  incisor  (Fig.  1).
 control  CT  scan  with  oral  contrast  showed  good  position  of
he  stent,  without  evidence  of  leakage.  The  patient’s  clin-
cal  status  improved  and  began  to  swallow  normally,  but
howed  numerous  episodes  of  reﬂux  despite  PPI  use.  We
eave  the  PSEMS  for  26  days  beside  the  reﬂux  symptoms.
uring  the  endoscopic  procedure  to  remove  the  stent  the
resence  of  tissue  embedding  along  the  covered  portion  of
he  PSEMS  was  noted  (Fig.  2).  The  stent  was  pulled  out  with
n  alligator  forceps  with  out  major  complications  and  the
over  of  the  PSEMS  was  seen  to  be  totally  destroyed  (Fig.  3).
iscussion
ith  the  possible  new  applications  of  PSEMS  in  benign  GI
isease,  one  of  the  main  concerns  is  about  the  duration
nd  characteristics  of  the  cover.  The  currently  available
sophageal  stents  are  easy  to  insert  and  can  usually  be
emoved  safely  within  a  few  weeks  of  the  placement.6 Actu-
lly,  the  PSEMS  are  not  FDA  approved  in  benign  GI  diseases,
F
digure  2  The  image  shows  the  presence  of  tissue  embedment
long the  covered  portion  of  the  PSEMS.
ut  are  used  as  alternative  treatment  in  some  particular
ases.7
The  Ultraﬂex  covered  stent  is  made  of  silicone  a  material
ith  a  good  resistance  to  heat  and  acid  exposure.  The  PSEMS
omplications  are  severe  and  expensive  (stent  in  stent
ethod  or  surgery).8 The  used  of  covered  self-expanding
etallic  stents  for  intra-thoracic  leakage  treatment  after
sophageal  perforations  had  reported  effectiveness  of  77%,igure  3  After  removal  of  the  stent,  the  image  shows  total
estruction  of  the  covered  portion.
CT
R
1
1Total  loss  of  the  covering  of  a  metallic  stent  
benign  GI  disease.  Recently,  the  stent  migration  and  tissue
embedding  became  one  of  the  most  frequent  complications
of  the  PSEMS.10 One  study  about  the  use  of  PSEMS  in  benign
GI  diseases  showed  cover  rupture  (Ultraﬂex)  in  seven  of
twenty-three  cases.11 Another  study,  including  71  stents
placement,  reports  a  clinical  effectiveness  and  mortality
of  76%  and  2%  respectively.  But,  19/71  stents  need  to  be
removed  early  because  stent  complications  and  8/19  stents
had  tissue  in-  and/or  overgrowth.  However,  the  article  does
not  specify  whether  tissue  in-  and/or  overgrowth  was  on  the
cover  or  in  the  bare  area  of  the  stent.10
In  our  report,  even  when  the  PSEMS  was  early  removed
(26  days),  the  cover  was  totally  destroyed.  As  we  mentioned
early,  the  patient  suffered  severe  reﬂux  episodes  despite
use  of  double  doses  of  PPI  and  head  bed  elevation.  We
think  that  the  use  of  PPI  may  totally  suppress  the  gastric
acid  content  and  alkaline  reﬂux  was  present.  The  alkaline
content  could  be  one  important  factor  in  damaging  the  stent
cover.  We  have  the  theory  that  the  tissue  contact  with  the
biliar  content  promotes  an  inﬂammatory  and  pro-thrombotic
response  that  could  be  the  potential  explanation  of  early  in-
and/or  tissue  overgrowth  in  the  bare  area  of  the  stent.12
More  information  is  requiered  about  the  use  of  PSEMS
in  benign  esophageal  disease.  Several  questions  about  the
covered  need  to  be  answered:  1)  the  potential  role  of
alkaline-acid  reﬂux,  2)  durability  of  the  cover,  3)  time  of
stent  removal.  In  our  experience  we  may  recommend  endo-
scopic  surveillance  of  the  stent  and  to  removed  it  in  less
than  3  weeks.
Due  to  likely  increase  in  the  number  indications  of  cov-
ered  and  PSEMS  in  benign  GI  diseases,  we  believe  that  a
complete  reevaluation  of  the  stent  composition  is  needed
to  avoid  potentially  fatal  complications.Funding
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